Mike Ison
Medical Director, Transplant & Immunocompromised Host Infectious Diseases Service · University of Wisconsin Hospitals and Clinics
Credentials: · · · · · ·
History
- Present
Transplant & Immunocompromised Host Infectious Diseases Service · University of Wisconsin Hospitals and Clinics
PresentRespiratory Diseases Division · University of Washington School of Medicine
Research
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
New England Journal of Medicine · 2023 · 648 citations
Clinical Infectious Diseases · 2019 · 462 citations
Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study
Clinical Infectious Diseases · 2021 · 333 citations
19 papers
- NT
17 papers · 9 as a fellow
17 papers
16 papers
15 papers
13 papers
12 papers · 1 as a fellow
11 papers
Grants
- 2016–2022
Microbiology and Infectious Diseases Biological Resource Repository (MID-BRR)
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $3.2M · American Type Culture Collection
- 2011–2012
Achieving Consensus on High Risk Donor to Improve Access to Organ Transplants
Agency for Healthcare Research and Quality · R13
Contact PI · $49.9K · Northwestern University
- 2006–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $457 · Northwestern University
Clinical trials
- 2010–2012
Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients
Principal investigator · Completed
Michael Ison
- 2010–2011
Principal investigator · Withdrawn
Midwestern University
- 2011–2017
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Study chair · Completed
National Institute of Allergy and Infectious Diseases (NIAID)